Can NIB Shares Outperform the Market in 2024?

2 min read | December 21, 2023 04:37 PM AEDT | By Team Kalkine Media

NIB Holdings Limited (ASX: NHF) has experienced a lackluster performance in 2023, with shares losing 4.5% of their value since the beginning of the year. In contrast, the ASX 200 index has shown a positive trend, rising approximately 7% during the same period. Looking ahead to 2024, several factors could influence the performance of NIB shares. 

One crucial factor is the overall market performance. If there is a global cut in interest rates, it could potentially boost investor sentiment and drive shares higher. Additionally, premium rate increases in the health insurance industry could impact NIB's share price. Reports suggest that the industry is seeking an average premium rate increase of 6% for the next year, a notable jump from the increases seen in recent years. This analysis reflects the potential influences of broader market trends and the healthcare industry on NIB shares, offering insights into ASX healthcare stocks. 

Goldman Sachs, while noting that the 6% rate increase is higher than expected, remains optimistic about NIB shares. The broker has assigned a buy rating and a $8.40 price target, implying a potential upside of 13.5% over the next 12 months. Furthermore, Goldman Sachs anticipates a fully franked 3.9% dividend yield for FY 2024, providing investors with a total potential return of approximately 17.5%. 

Another element to consider is the potential impact of changes to the National Disability Insurance Scheme (NDIS). NIB entered the NDIS market in 2022 through the acquisition of plan manager Maple and has expanded its presence in the sector through subsequent acquisitions. However, proposed changes to the NDIS could pose challenges, with a review expected to be released in 2024. 

Investors will closely monitor these factors, and the outcome of the NDIS review, to gauge the trajectory of NIB shares in 2024. Despite the headwinds, the positive outlook from Goldman Sachs suggests that the private health insurer has the potential for a more favorable performance in the coming year. 


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.